pipeline-prospector-insert-v1
X

Find Novel Oncology Drugs in Discovery in UNITED STATES

A collaboration with SCORR Marketing

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type

            Companies

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Undisclosed

            Therapeutic Area: Oncology

            Highest Development Status: Discovery Product Type: Small molecule

            Partner/Sponsor/Collaborator: Pfizer

            Deal Size: $507.0 million Upfront Cash: $15.0 million

            Deal Type: Collaboration January 09, 2020

            Details:

            This license and collaboration agreement is to develop small-molecule inhibitors of eukaryotic initiation factor 4E, a key oncogenic driver located downstream from both the RAS and PI3K pathways.